Comparison between Concord Biotech IPO and TVS Supply Chain Solutions IPO.
Concord Biotech IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while TVS Supply Chain Solutions IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Concord Biotech IPO is up to ₹1,550.52 Cr whereas the issue size of the TVS Supply Chain Solutions IPO is up to ₹880.00 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of TVS Supply Chain Solutions IPO is ₹197.00 per share.
| Concord Biotech IPO | TVS Supply Chain Solutions IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹1 per share |
| Issue Price (Lower) | ₹705.00 per share | ₹187.00 per share |
| Issue Price (Upper) | ₹741.00 per share | ₹197.00 per share |
| Issue Price (Final) | ₹741.00 per share | ₹197.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹70.00 per share | |
| Market Lot Size | 20 shares | 76 shares |
| Fresh Issue Size | 0 shares | 3,04,56,852 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹600.00 Cr |
| OFS Issue Size | 2,09,25,652 shares | 1,42,13,198 shares |
| OFS Issue Size (Amount) | up to ₹1,550.52 Cr | up to ₹280.00 Cr |
| Issue Size Total | 2,09,25,652 shares | 4,46,70,050 shares |
| Issue Size Total (Amount) | up to ₹1,550.52 Cr | up to ₹880.00 Cr |
Concord Biotech IPO opens on Aug 04, 2023, while TVS Supply Chain Solutions IPO opens on Aug 10, 2023. The closing date of Concord Biotech IPO and TVS Supply Chain Solutions IPO is Aug 08, 2023, and Aug 14, 2023, respectively.
| Concord Biotech IPO | TVS Supply Chain Solutions IPO | |
|---|---|---|
| Anchor Bid Date | Aug 03, 2023 | Aug 09, 2023 |
| Issue Open | Aug 04, 2023 | Aug 10, 2023 |
| Issue Close | Aug 08, 2023 | Aug 14, 2023 |
| Basis Of Allotment (Tentative) | Aug 11, 2023 | Aug 18, 2023 |
| Initiation of Refunds (Tentative) | Aug 14, 2023 | Aug 21, 2023 |
| Credit of Share (Tentative) | Aug 17, 2023 | Aug 22, 2023 |
| Listing date (Tentative) | Aug 18, 2023 | Aug 23, 2023 |
| Anchor Lockin End date 1 | Sep 10, 2023 | Sep 17, 2023 |
| Anchor Lockin End date 2 | Nov 09, 2023 | Nov 16, 2023 |
Concord Biotech IPO P/E ratio is 32.29, as compared to TVS Supply Chain Solutions IPO P/E ratio of 189.42.
| Concord Biotech IPO | TVS Supply Chain Solutions IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 44.08 | 46.65 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 44.08 | 41.6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 32.29 | 189.42 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹7752.06 Cr. | ₹8746.00 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.06% | 5.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.27% | 7.64% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹20.79 | ₹1.04 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20% | 5.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Concord Biotech IPO Retail Individual Investors (RII) are offered 73,20,479 shares while in TVS Supply Chain Solutions IPO retail investors are offered 73,20,479 shares. Qualified Institutional Buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 1,34,01,016 shares in TVS Supply Chain Solutions IPO.
| Concord Biotech IPO | TVS Supply Chain Solutions IPO | |
|---|---|---|
| Anchor Investor Reservation | 62,74,695 shares | 2,01,01,522 shares |
| Market Maker Reservation | ||
| QIB | 41,83,130 shares | 1,34,01,016 shares |
| NII | 31,37,348 shares | 67,00,507 shares |
| RII | 73,20,479 shares | 44,67,005 shares |
| Employee | 10,000 shares | |
| Others | ||
| Total | 2,09,25,652 shares | 4,46,70,050 shares |
Concord Biotech IPO subscribed 24.87x in total, whereas TVS Supply Chain Solutions IPO subscribed 2.85x.
| Concord Biotech IPO | TVS Supply Chain Solutions IPO | |
|---|---|---|
| QIB (times) | 67.67x | 1.37x |
| NII (times) | 16.99x | 2.44x |
| Big NII (times) | 19.30x | 2.39x |
| Small NII (times) | 12.37x | 2.55x |
| RII (times) | 3.78x | 7.89x |
| Employee (times) | 24.48x | |
| Other (times) | ||
| Total (times) | 24.87x | 2.85x |
